Bold reality: a life-changing drug once denied by insurers can become accessible when outside review rules kick in—and that difference saves more than money. Here’s how a North Carolina family navigated the system, and why external appeals matter for patients everywhere.
When Paxton Pope, a 13-year-old with a rare genetic condition, faced up to 12 seizures per hour, his doctors believed an almost $800,000-a-year medication could dramatically reduce those episodes. But for months, his insurer rejected covering the drug. The Popes, from Davidson, NC, weren’t ready to give up. They discovered a little-known Affordable Care Act provision that permits an outside, state-run panel to reassess insurer decisions after internal appeals fail. This option, often overlooked, ultimately overturned the initial denial.
In the months that followed, Paxton’s life began to change. Maggie Pope, his mother, reported a striking improvement: seizures dropped from as many as twelve per hour to about eight per day. He also started regaining cognitive and social skills he’d been losing, such as holding conversations and reading comprehension. For the first time, Paxton could participate on his school’s flag football team, a milestone his family cherishes.
“We were over the moon,” Maggie recalled. “I looked at him and he was smiling. I asked if he knew he was having fewer seizures, and he nodded.”
The overturned denial came from the North Carolina Department of Insurance, a state agency that oversees insurers and guides patients through denied-claim challenges. Across the United States, every state has some version of an insurance department or commission, though programs and resources vary. Experts emphasize that these agencies can provide an additional route beyond an insurer’s internal appeals process: an external review.
If you’re dealing with bills that feel out of line or with coverage or service denials—whether for health care, home repairs, or auto-related issues—consider reaching out to your state insurance office or an external review program. NBC News has provided contact channels for readers seeking guidance through such denials.
Under federal law, when a doctor says a treatment is medically necessary but an insurer denies it, an external review can send the case to an independent panel. That panel assigns a doctor to review the claim and issue a binding decision. It’s a powerful safeguard, but its visibility remains limited—often a “well-kept secret,” as one advocate put it—so patients may not realize the option exists.
“Their opinion carries enormous weight,” said Michele Johnson, executive director of the Tennessee Justice Center, describing the impact of medical experts in these reviews. “If you can get your doctor on board to advocate for you, it makes a big difference.”
The scope of denial appeals is broad. Millions of Americans have claims denied annually. A 2023 National survey by KFF found that 58% of insured adults reported trouble with health coverage, and The Commonwealth Fund reported that about half of Americans received a medical bill that should have been covered. These figures highlight a gap between expectations and the reality of insurance denials, and they underscore why external review can be a crucial, sometimes life-saving option.
For the Popes, the external-review process required some administrative steps. They submitted a pre-application to determine eligibility, gathered necessary documents, and provided medical records and seizure data. The doctor had initially requested Ravicti, a medication approved for urea cycle disorders, though not specifically approved for Paxton’s condition. Early research suggested that Ravicti could help reduce seizures tied to the SLC6A1 mutation, a factor in Paxton’s epilepsy and related developmental issues.
The family’s fear was tangible. Without the medication, Paxton risked severe health consequences, including death from seizures or losing the traits that make him uniquely Paxton.
There was no guarantee the external review would overturn the denial. The program, Smart NC, reviewed 282 cases through November and overturned 153—roughly 53%—a promising rate by any measure.
Commissioner Mike Causey noted that the insurance agency’s mission includes enforcing laws and ensuring fair practices. Still, experts caution that the external review system isn’t a magic wand; it’s part of a broader, imperfect health-care framework that often burdens families with long, complex processes that can feel like a full-time job during a health crisis.
For the Popes, the turnaround came on August 5, a five-month window from initial prescription submission to a successful overturn. Paxton’s story stands not only as a medical triumph but as a testament to the value of persistent advocacy, clear documentation, and the potential of state-run external reviews to change outcomes.
Greyson Pope hopes the broader public learns about these resources: a denial isn’t necessarily the end of the story. And with doctors, advocates, and state programs working together, patients can push for the care they need—even when the odds initially look overwhelming.
Would you consider pursuing an external review if you or a loved one faced a similar denial? What are the trade-offs you’d weigh when deciding to challenge an insurer through a state process? Share your thoughts in the comments.
